EXTH-99. SYSTEMIC AND BRAIN PHARMACOKINETICS OF A GABAA RECEPTOR AGONIST, AMLAL-101, AS AN INVESTIGATIONAL THERAPEUTIC FOR THE TREATMENT OF PRIMARY AND METASTATIC BRAIN CANCERS

Authors: Aniruddha Karve, Taukir Ahmed, Janki Desai, Debanjan Bhattacharya, Donatien Kamdem Toukam, Sidharth Gadgil, Merissa Pemberton, David Plas, Gary Gudelsky, Larry Sallans, James Cook, Pankaj Desai, Daniel Pomeranz Krummel, Soma Sengupta

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.897

Source: Full article


Abstract

Abstract